Sauer A, Villard O, Bourcier T, Speeg-Schatz C, Candolfi E
Service d'ophtalmologie, hôpitaux universitaires de Strasbourg, nouvel hôpital civil, BP 426, 67091 Strasbourg, France.
J Fr Ophtalmol. 2013 Jan;36(1):76-81. doi: 10.1016/j.jfo.2012.05.004. Epub 2012 Dec 6.
Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects: 30% of the world population may be affected, with wide variability. However, despite high seroprevalence, the incidence of ocular toxoplasmosis (OT) is limited to about 2% of infected patients; thus, about one million patients in France may be estimated to have active or cicatricial OT. Microbiological tools available to the clinician have considerably advanced over the last two decades, allowing the diagnosis of toxoplasmosis to be confirmed in the vast majority of suspected cases. Regardless of the route of infection (congenital or acquired), laboratory confirmation of OT plays a major role in the patient's management, particularly in atypical cases.
全球30%的人口可能受到影响,存在很大差异。然而,尽管血清阳性率很高,但眼部弓形虫病(OT)的发病率仅限于约2%的感染患者;因此,据估计法国约有100万患者患有活动性或瘢痕性OT。在过去二十年中,临床医生可用的微生物学工具取得了很大进展,使得绝大多数疑似病例的弓形虫病诊断得以确诊。无论感染途径是先天性还是后天性,OT的实验室确诊在患者管理中都起着重要作用,特别是在非典型病例中。